Clinical trial
A Trial of Wellbutrin for Crohn's Disease
NCT00126373 · Altschuler, Eric, M.D., Other · Completed
Key facts
| NCT number | NCT00126373 |
|---|---|
| Title | A Trial of Wellbutrin for Crohn's Disease |
| Official title | A Randomized Controlled Trial of Wellbutrin for Crohn's Disease |
| Lead sponsor | Altschuler, Eric, M.D., Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Crohn Disease |
| Intervention type | Drug |
| Interventions | Wellbutrin (bupropion) |
| Enrollment | 1 |
| Start date | May 1, 2005 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Aug 4, 2005 |
| Last update posted | Jan 20, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: